BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12671840)

  • 1. Mechanisms activating proteolysis to cause muscle atrophy in catabolic conditions.
    Mitch WE; Price SR
    J Ren Nutr; 2003 Apr; 13(2):149-52. PubMed ID: 12671840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms activated by kidney disease and the loss of muscle mass.
    Mitch WE; Price SR
    Am J Kidney Dis; 2001 Dec; 38(6):1337-42. PubMed ID: 11728972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular mechanisms controlling protein degradation in catabolic states.
    Ding X; Price SR; Bailey JL; Mitch WE
    Miner Electrolyte Metab; 1997; 23(3-6):194-7. PubMed ID: 9387115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting.
    Tisdale MJ
    J Support Oncol; 2005; 3(3):209-17. PubMed ID: 15915823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytic mechanisms, not malnutrition, cause loss of muscle mass in kidney failure.
    Mitch WE
    J Ren Nutr; 2006 Jul; 16(3):208-11. PubMed ID: 16825021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms accelerating muscle atrophy in catabolic diseases.
    Mitch WE
    Trans Am Clin Climatol Assoc; 2000; 111():258-69; discussion 269-70. PubMed ID: 10881345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necessary but not sufficient: the role of glucocorticoids in the acidosis-induced increase in levels of mRNAs encoding proteins of the ATP-dependent proteolytic pathway in rat muscle.
    Price SR; Bailey JL; England BK
    Miner Electrolyte Metab; 1996; 22(1-3):72-5. PubMed ID: 8676830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of muscle protein degradation in sepsis by eicosapentaenoic acid (EPA).
    Khal J; Tisdale MJ
    Biochem Biophys Res Commun; 2008 Oct; 375(2):238-40. PubMed ID: 18703014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular signals activating muscle proteolysis in chronic kidney disease: a two-stage process.
    Du J; Hu Z; Mitch WE
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2147-55. PubMed ID: 15982920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting.
    Mitch WE; Bailey JL; Wang X; Jurkovitz C; Newby D; Price SR
    Am J Physiol; 1999 May; 276(5):C1132-8. PubMed ID: 10329962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolysis, the ubiquitin-proteasome system, and renal diseases.
    Debigaré R; Price SR
    Am J Physiol Renal Physiol; 2003 Jul; 285(1):F1-8. PubMed ID: 12788783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic acidosis stimulates protein metabolism in uremia.
    Mitch WE
    Miner Electrolyte Metab; 1996; 22(1-3):62-5. PubMed ID: 8676827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of ubiquitin-proteasome-dependent proteolysis in the remodelling of skeletal muscle.
    Taillandier D; Combaret L; Pouch MN; Samuels SE; Béchet D; Attaix D
    Proc Nutr Soc; 2004 May; 63(2):357-61. PubMed ID: 15294055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regulation of ubiquitin-proteasome dependent muscular proteolysis by hormones and nutrients].
    Attaix D; Combaret L; Taillandier D; Béchet D
    Journ Annu Diabetol Hotel Dieu; 2002; ():123-33. PubMed ID: 12525137
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of ubiquitin-proteasome pathway in skeletal muscle wasting in rats with endotoxemia.
    Chai J; Wu Y; Sheng ZZ
    Crit Care Med; 2003 Jun; 31(6):1802-7. PubMed ID: 12794423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms activating muscle protein degradation in chronic kidney disease and other catabolic conditions.
    Du J; Hu Z; Mitch WE
    Eur J Clin Invest; 2005 Mar; 35(3):157-63. PubMed ID: 15733069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The balance between glucocorticoids and insulin regulates muscle proteolysis via the ubiquitin-proteasome pathway.
    Bailey JL; Wang X; Price SR
    Miner Electrolyte Metab; 1999; 25(4-6):220-3. PubMed ID: 10681643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of the ubiquitin-proteasome pathway to overall muscle proteolysis in hypercatabolic patients.
    Biolo G; Bosutti A; Iscra F; Toigo G; Gullo A; Guarnieri G
    Metabolism; 2000 Jun; 49(6):689-91. PubMed ID: 10877190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms stimulating protein degradation to cause muscle atrophy.
    Price SR; Mitch WE
    Curr Opin Clin Nutr Metab Care; 1998 Jan; 1(1):79-83. PubMed ID: 10565334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel aspects on the regulation of muscle wasting in sepsis.
    Hasselgren PO; Menconi MJ; Fareed MU; Yang H; Wei W; Evenson A
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2156-68. PubMed ID: 16125115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.